| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $61,418,596 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM158187 | Molecular mechanism of MFS and MOP lipid transporters in cell wall biosynthesis. | 000 | 2 | NIH | 4/17/2026 | $362,062 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM163754 | Enhancing Faculty Mentorship of PhD Students in Biomedical Research | 000 | 1 | NIH | 6/11/2026 | $342,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM150916 | Molecular mechanisms of physical interactions between bacteria and their surroundings | 000 | 4 | NIH | 8/10/2026 | $368,444 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM152134 | Control and function of repressive chromatin domains | 000 | 3 | NIH | 5/8/2026 | $365,002 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM151237 | Developmental mechanisms that buffer mutational load in plants | 000 | 4 | NIH | 5/19/2026 | $359,629 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS143399 | Role of N6Methyladenosine (m6A) Reader Protein YTHDF1 in Microglial Mediated Neuroinflammation in Parkinson's Disease Models | 002 | 1 | NIH | 4/15/2026 | $576 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS143399 | Role of N6Methyladenosine (m6A) Reader Protein YTHDF1 in Microglial Mediated Neuroinflammation in Parkinson's Disease Models | 001 | 1 | NIH | 1/16/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31NS143399 | Role of N6Methyladenosine (m6A) Reader Protein YTHDF1 in Microglial Mediated Neuroinflammation in Parkinson's Disease Models | 000 | 1 | NIH | 1/16/2026 | $43,700 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01NS133739 | Defining the mechanisms of MSC extracellular vesicle modulation of microglia metabolism and bioenergetics in traumatic brain injury recovery | 000 | 3 | NIH | 6/19/2026 | $622,410 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DK132673 | Transfer application - Leptin in the VMH and energy balance | 001 | 5 | NIH | 6/19/2026 | $377,500 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL173931 | Metabolic control of human endothelial development via the COUP-TF/1-deoxysphingosine axis | 000 | 3 | NIH | 5/13/2026 | $547,363 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 001 | 4 | NIH | 2/11/2026 | $73,682 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 4 | NIH | 2/5/2026 | $111,577 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | D43TW012481 | Digital Mobile Technologies to study Tuberculosis: A Multi-disciplinary Program | 000 | 4 | NIH | 2/5/2026 | $50,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | DP2AI184725 | Evolution of heat tolerance and drug resistance in Cryptococcus | 000 | 3 | NIH | 7/24/2026 | $443,944 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM147312 | Supplement: Functional Analysis of the Anti-Müllerian Hormone as a Convergently Acquired Master Sex Determination Gene | 001 | 4 | NIH | 7/6/2026 | $174,832 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM147312 | Supplement: Functional Analysis of the Anti-Müllerian Hormone as a Convergently Acquired Master Sex Determination Gene | 000 | 4 | NIH | 4/3/2026 | $310,896 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM147209 | Spatial genetics investigation of multinucleated cells | 000 | 5 | NIH | 6/19/2026 | $377,500 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI202814 | Parasite glycosylphosphatidylinositol Libraries: Expanding the Toolbox for Parasite Glycobiology | 000 | 1 | NIH | 7/3/2026 | $228,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI196741 | Novel approaches to predict strength and breadth of influenza vaccine response | 000 | 1 | NIH | 5/12/2026 | $805,866 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DE035487 | Engineered Synthetic Low-Density Lipoprotein Nanoparticles for Enhanced Cancer Immunotherapy in Head and Neck Cancer | 000 | 1 | NIH | 2/18/2026 | $644,452 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R00AI173531 | Separating late gene transcription from viral DNA replication in KSHV | 001 | 4 | NIH | 8/19/2026 | $242,200 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | K22AG088111 | Molecular Determinants of Age-Related Cognitive Decline in the Basal Forebrain to Lateral Entorhinal Cortex Circuit | 000 | 1 | NIH | 3/19/2026 | $198,352 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | S10OD040213 | Sony SH800 Cell Sorter | 000 | 1 | NIH | 6/11/2026 | $317,073 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI194190 | Cellular and molecular profiling of artemisinin-induced persister phenotypes in P. falciparum | 000 | 1 | NIH | 7/7/2026 | $436,750 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01HL178801 | Long Noncoding RNA Regulation in Complement-Mediated Endothelial Barrier Disruption: From Mechanism to Therapy | 000 | 1 | NIH | 8/3/2026 | $588,284 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI198196 | Pan-fungal vaccine development targeting recurrent vulvovaginal candidiasis | 000 | 1 | NIH | 7/9/2026 | $759,935 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21MH142318 | Rural and Urban Differences in Social Media Use, Online Experiences, and Mental Health Among Socially Disconnected Adolescents | 000 | 1 | NIH | 8/18/2026 | $405,505 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI195646 | Molecular analysis of transcription termination by RNA polymerase II in trypanosomatids | 000 | 1 | NIH | 8/7/2026 | $675,790 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA304246 | Modeling Bone Breast Tumor Cell Interactions to Predict and Prevent Metastasis | 000 | 1 | NIH | 8/12/2026 | $479,860 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI197675 | Interorganellar communication and dynamics in the divergent eukaryotic parasite Toxoplasma gondii | 001 | 1 | NIH | 8/5/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F31AI197675 | Interorganellar communication and dynamics in the divergent eukaryotic parasite Toxoplasma gondii | 000 | 1 | NIH | 8/5/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA314296 | Optimization of a public neoantigen-based cancer prevention strategy | 000 | 1 | NIH | 5/19/2026 | $659,570 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01GM164352 | Somatic and germline fate decisions in dynamic stem cell utilization by tapeworms | 000 | 1 | NIH | 8/6/2026 | $442,250 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01DA067308 | Integrated Biomedical-Behavioral HIV Prevention for Women in Non-carceral Correctional Supervision Programs: A Hybrid Type II Trial of E-WORTH South in Alabama | 000 | 1 | NIH | 8/17/2026 | $608,658 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM165843 | Modeling the Emergence Cascade: From Wildlife Pathogen Circulation to Human Outbreak Amplification | 000 | 1 | NIH | 7/16/2026 | $393,673 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM161349 | Glycosidase Inhibitors and Related Compounds | 000 | 1 | NIH | 7/15/2026 | $2,052,103 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | F32AI202941 | Genomic regulation of transposon-mediated horizontal gene transfer in the fungal pathogen Aspergillus fumigatus | 000 | 1 | NIH | 8/10/2026 | $75,880 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | RF1NS141022 | Neuroinflammatory Epitranscriptomic Mechanisms in Parkinson's Disease | 000 | 1 | NIH | 5/12/2026 | $1,297,188 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG093018 | Navigating the Journey to Middle Age in the SHAPE Study | 001 | 2 | NIH | 7/15/2026 | $647,837 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21TR005505 | Repurposing the PI3Kα inhibitor Alpelisib for the treatment of Multiple Hereditary Exostoses | 000 | 1 | NIH | 4/27/2026 | $415,250 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01CA299080 | Calcium Nanoparticles to Enhance Immuno-Radiotherapy | 000 | 1 | NIH | 3/24/2026 | $618,236 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R00AI186598 | Ribonucleoprotein complexes involved in the late phase of HIV-1 replication | 000 | 3 | NIH | 8/6/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R21AI202073 | Characterization of pan-fungal monoclonal antibodies targeting Aspergillus | 000 | 1 | NIH | 8/17/2026 | $228,000 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AI140719 | Cryptococcal vaccine development based on strong immunity induced by morphological strains | 000 | 8 | NIH | 4/24/2026 | $577,287 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R33AI169204 | Novel Nanoparticle Respiratory Tract Mucosal Vaccine | 000 | 5 | NIH | 7/22/2026 | $391,919 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R35GM158412 | Merging bacteriophage biology with microbial glycobiology | 000 | 2 | NIH | 6/19/2026 | $377,500 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG074216 | APOE4 effects on glia-neuron interaction in the olfactory bulb | 001 | 4 | NIH | 2/23/2026 | $45,020 |
| | 2026 | 2026 | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 310 E CAMPUS RD RM 409 | ATHENS | GA | 30602-1589 | CLARKE | USA | R01AG074216 | APOE4 effects on glia-neuron interaction in the olfactory bulb | 000 | 4 | NIH | 2/12/2026 | $405,192 |
|
